Bladder cancer (BC) is the 9th most common cancer worldwide, but little progress has been made in improving patient outcomes over the last 25 years. The King’s Health Partners (KHP) BC biobank was established to study unanswered, clinically relevant BC research questions.
Read this paper that describes the cohort profile of KHP bladder cancer biobank. The biobank has assembled a rich data and tissue repository that is clinically and demographically representative of the local South East London BC population.